Skip to main content
Premium Trial:

Request an Annual Quote

Ciphergen CEO Joins Genomica s Board of Directors

NEW YORK, March 14 – Bioinformatics company Genomica said Wednesday it had appointed William Rich, CEO of Ciphergen Biosystems, to its board of directors, signaling the company’s growing interest in the field of proteomics.

"His experience in the industry in general and, in particular, the emerging field of protein-based biology research known as proteomics, will help us as we expand our product line and functionality," Teresa Ayers, CEO of Genomica, said in a statement.

Ciphergen of Fremont, Calif., was among the first companies to market protein chips to detect and validate proteins.

Ayers could not immediately be reached for comment regarding Genomica’s plans for the proteomics sector.

Genomica currently develops software that is designed to help researchers integrate and interpret genomics data culled from a variety of sources.

The company’s customers include AstraZeneca, GlaxoSmithKline and Aventis. Genomica of Boulder also has a deal to develop software that can be integrated with Applied Biosystems’ hardware.


The Scan

Study Finds Sorghum Genetic Loci Influencing Composition, Function of Human Gut Microbes

Focusing on microbes found in the human gut microbiome, researchers in Nature Communications identified 10 sorghum loci that appear to influence the microbial taxa or microbial metabolite features.

Treatment Costs May Not Coincide With R&D Investment, Study Suggests

Researchers in JAMA Network Open did not find an association between ultimate treatment costs and investments in a drug when they analyzed available data on 60 approved drugs.

Sleep-Related Variants Show Low Penetrance in Large Population Analysis

A limited number of variants had documented sleep effects in an investigation in PLOS Genetics of 10 genes with reported sleep ties in nearly 192,000 participants in four population studies.

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.